Point of Care Molecular Diagnostics Market

Industry Overview

The global point of care molecular diagnostics market is expected to grow from USD 8.70 billion in 2023 to USD 10.12 billion by 2030 at a compound annual growth rate of (CAGR) 2.5% during the forecast period ranging from 2025 to 2030.

Molecular diagnosis refers to the detection process of a particular sequence of DNA or RNA that may be the reasons for a disease. The process helps healthcare professionals to detect diseases using specific technologies in POC settings and may involve simple glucose testing to complex coagulation testing. POC testing is preferred over conventional lab testing due to quicker results, lower costs, and better outcomes.

The growth of the POC molecular diagnostics market has been significant due to growing awareness, economic advantages, higher preference of the geriatric population for health surveillance, growing incidents of infectious diseases, higher adoption of decentralized diagnostics, availability of different types of products and services, and higher demand for assays and kits.

One of the significant factors that prevents widespread adoption and expansion of the global point of care molecular diagnostics market is the inadequate reimbursements policies and the high cost involved in the process. However, rapid development in the molecular testing products and the rising adoption of these products in the POC facilities are presenting novel growth opportunities to the market.

Market Segmentation

Insight by Application

The global point of care molecular diagnostics market is divided by application into hospital-acquired infection, hepatitis, oncology, respiratory diseases, sexually transmitted diseases, and other segments. Out of all these segments, the respiratory diseases segment will account for the largest share of the market during the forecast period due to higher prevalence of influenza and tuberculosis as well as the technological improvements in investigative tests. It is also attributed to the higher preference of POC molecular diagnostics.

Insight by Technology

The global point of care molecular diagnostics market is divided by technology into INAAT, R-PCR, and other segments, where the R-PCR segment is expected to grow more and contribute the larger share to the market due to ease of use and higher adoption and usage of this technology in genomics and proteomics.

Insight by Product & Services

The global point of care molecular diagnostics market is divided by product and services into instruments, assays & kits, and software and services. Out of all these different segments, the assays & kits segment is expected to grow at a faster rate during the forecast period due to the growing number of infectious diseases.

Insight by End-User

The global point of care molecular diagnostics market is divided by the different end users into research institutes, decentralized laboratories, hospital, home care, and other segments. Out of them, the decentralized laboratories segment is expected to grow more and contribute the larger share due to the ability to provide quick and more accurate molecular analysis and results.

Insight by Test Location

The global point of care molecular diagnostics market is divided by test location into OTC test location and the POC test location segments, where the former is expected to continue holding the larger share of the market during the forecast period. This is attributed to the ability to offer early diagnosis and constant patient monitoring and lower costs. The point of care test location segment will however grow at a faster rate due to its ability to produce quick results and greater portability.

Global Point of Care Molecular Diagnostics Market Report Coverage

Industry Dynamics

Industry Trends

The growing effort of the market players to develop and launch newer and better POC testing products is a significant trend noticed in the market. Development in nanotechnology has also been significant to result in product miniaturization, ease of use, convenience, and any-point testing even in remote location and areas with limited resources. Another significant development is the integration of 3D printing which enhances performance and fabrication of POC devices. In addition, use of flexible sensors and wireless communication allow real-time patient monitoring thereby facilitating preventative healthcare and preventing disease outbreaks, which is also a notable innovation.

Growth Drivers

The most significant factor that drives the growth of the global point of care molecular diagnostics market is the growing demand for CLIA-waived molecular POC tests. In addition, there is a higher penetration of POC molecular diagnostic tests in developing economies which is also propelling the growth of the market. In addition, the growing R&D activities in molecular diagnostic testing and higher funding from the government bodies and private entities for the development of cost-effective solutions to meet the rising customer demand is also fueling the market growth. Apart from that, higher preference for fast and portable tests, continuous development of product quality and efficiency, and new product launches are also driving the growth of the market.

Challenges

The most significant factor that hinders the growth of the global point of care molecular diagnostics market is the longer time taken for product development. In addition, the stringent regulatory requirements for launching a new product also poses significant challenge to the growth of the POC molecular diagnostics market.

Opportunities

The significant rise in the demand for faster testing and patient-centric healthcare services at point of care facilities are presenting significant growth opportunities to the global POC molecular diagnostics market during the projected period. This includes clinics and retail pharmacies as well. Moreover, the continuous involvement of the market players in developing new POC testing products to exploit the market opportunities and opening new avenues for growth to the global POC market.

Geographic Overview

North America will continue to contribute the largest share to the point of care molecular diagnostics market during the forecast period due to the growing number of infectious diseases, rise in demand for fast and portable tests, higher government initiatives, increased emphasis on preventive care to reduce the cost burden, and the rise in the number of CLIA product approvals.

Asia-Pacific market will grow at the fastest rate during the same period due to the large population base as well as the growing demand for influenza A/B tests. It is also attributed to the growing initiatives by government and market players to promote such diagnostics industry.

Competitive Insight

Major players in the industry are investing in the development of innovative and advanced products, which is strengthening their position in the market. Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics are some of the key players offering a point of care molecular diagnostics products.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States.

Danaher Corporation is an American global conglomerate founded by brothers Steven and Mitchell Rales in 1984. Headquartered in Washington, D.C. The company designs, manufactures and markets medical, industrial and commercial products and services.

Recent Developments by Key Players

Abbott Laboratories had cleared the company's two new over-the-counter glucose monitoring devices, expanding its presence in a fast-growing, multi-billion-dollar market.

The Point of Care Molecular Diagnostics Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Application
  • Hospital-acquired infection
  • Hepatitis
  • Oncology
  • Respiratory diseases
  • Sexually transmitted diseases
  • Others
• By Technology
  • INAAT
  • R-PCR
  • Others
• By Product & Services
  • Instruments
  • Assays & kits
  • Software and services
• By End-User
  • Research institutes
  • Hospital
  • Decentralized laboratories
  • Home care
  • Others

Geographical Segmentation

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research